On the role of IRS2 in the regulation of functional β-cell mass

Archives of Physiology and Biochemistry

Volumn 112, Issue 2, 2006, Pages 65-73

  Niessen, Markus ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

cell; Apoptosis; Diabetes; Insulin receptor substrates; IRS2; Proliferation

Indexed keywords

ALKALINE PHOSPHATASE; CASPASE 9; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; GLUCOSE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLECKSTRIN; SOMATOMEDIN BINDING PROTEIN 1;

APOPTOSIS; CELL GROWTH; CELL ISOLATION; CHO CELL; CONFERENCE PAPER; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SYNTHESIS; LIGAND BINDING; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DIABETES MELLITUS; HUMANS; INSULIN-SECRETING CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; PHOSPHOPROTEINS;

MAMMALIA;

EID: 33748675684     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450600711409     Document Type: Conference Paper

References (69)

1. Amacker-Francoys I, Mohanty S, Niessen M, Spinas GA, Trub T. 2005. The metabolisable hexoses D-glucose and D-mannose enhance the expression of IRS-2 but not of IRS-1 in pancreatic beta-cells. Exp Clin Endocrinol Diabetes 113(8):423-9.
2. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, III, Johnson RS, Kahn CR. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372(6502):186-90.
3. Araki E, Oyadomari S, Mori M. 2003. Endoplasmic reticulum stress and diabetes mellitus. Intern Med 42(1):7-14.
4. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB. 1992. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130(1):167-78.
5. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. 2001. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108(11):1631-8.
6. Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, Han Z, Polonsky KS, Permutt MA. 2004. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 114(7):928-36.
7. Bohni R, Riesgo-Escovar J, Oldham S, Brogiolo W, Stocker H, Andruss BF, Beckingham K, Hafen E. 1999. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97(7):865-75.
8. Bonner-Weir S. 2000. Life and death of the pancreatic beta cells. Trends Endocrinol Metab 11(9):375-8.
9. Bonner-Weir S. 2001. beta-cell turnover: its assessment and implications. Diabetes 50 (Suppl 1):S20-S24.
10. Bonner-Weir S, Deery D, Leahy JL, Weir GC. 1989. Compensatory growth of pancreatic beta-cells in adult rats after shortterm glucose infusion. Diabetes 38(1):49-53.
11. Briaud I, Dickson LM, Lingohr MK, McCuaig JF, Lawrence JC, Rhodes CJ. 2005. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J Biol Chem 280(3):2282-93.
12. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin, M. 2006. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124(3):601-13.
13. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K, et al. 2001. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15(17):2203-8.
14. Chick WL,Warren S, Chute RN, Like AA, Lauris V, Kitchen KC. 1977. A transplantable insulinoma in the rat. Proc Natl Acad Sci USA 74(2):628-32.
15. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ, 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292(5522):1728-31.
16. Choudhury AI, Heffron H, Smith MA, Al-Qassab H, Xu AW, Selman C, Simmgen M, Clements M, Claret M, Maccoll G, et al. 2005. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest 115(4):940-50.
17. Dickson LM, Rhodes CJ. 2004. Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287(2): E192-8.
18. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, de Jong R, Oltersdorf T, et al. 2005. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25(5):1869-78.
19. Fantin VR, Wang Q, Lienhard GE, Keller SR. 2000. Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am J Physiol Endocrinol Metab 278(1):E127-33.
20. Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, Perego C, Usellini L, Nano R, Bonini P, Bertuzzi F, et al. 2001. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50(6):1290-301.
21. Frodin M, Sekine N, Roche E, Filloux C, Prentki M, Wollheim CB, Van Obberghen E. 1995. Glucose, other secretagogues, and nerve growth factor stimulate mitogen-activated protein kinase in the insulin-secreting beta-cell line, INS-1. J Biol Chem 270(14):7882-9.
22. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, et al. 2003. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112(2):197-208.
23. Giovannone B, Scaldaferri ML, Federici M, Porzio O, Lauro D, Fusco A, Sbraccia P, Borboni P, Lauro R, Sesti G. 2000. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev 16(6):434-41.
24. Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, et al. 2003. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112(10):1521-32.
25. Hennige AM, Ozcan U, Okada T, Jhala US, Schubert M, White MF, Kulkarni RN. 2005. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells. Am J Physiol Endocrinol Metab 289(2):E337-46.
26. Hugl SR, White MF, Rhodes CJ. 1998. Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substratemediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J Biol Chem 273(28):17771-9.
27. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, Montminy M. 2003. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17(13):1575-80.
28. Johnston AM, Pirola L, Van Obberghen E. 2003. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett 546(1):32-6.
29. Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S, Weir GC. 1999. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 274(20):14112-21.
30. Kaburagi Y, Yamauchi T, Yamamoto-Honda R, Ueki K, Tobe K, Akanuma Y, Yazaki Y, Kadowaki T. 1999. The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family. Endocr J 46 (Suppl):S25-S34.
31. Kaiser N, Corcos AP, Sarel I, Cerasi E. 1991. Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. Endocrinology 129(4):2067-76.
32. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. 1995. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270(40):23780-4.
33. Kaufman RJ, Scheuner D, Schroder M, Shen X, Lee K, Liu CY, Arnold SM. 2002. The unfolded protein response in nutrient sensing and differentiation. Nat Rev Mol Cell Biol 3(6):411-21.
34. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU. 1985. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4(2):110-25.
35. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, et al. 2000. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49(11):1880-9.
36. Kubota N, Terauchi Y, Tobe K, Yano W, Suzuki R, Ueki K, Takamoto I, Satoh H, Maki T, Kubota T, et al. 2004. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 114(7):917-27.
37. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. 1999a. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96(3):329-39.
38. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, Hanahan D, Kahn CR. 1999b. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured betacell lines. J Clin Invest 104(12):R69-75.
39. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR. 2002. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 31(1):111-5.
40. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y, White MF. 2004. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114(7):908-16.
41. Lingohr MK, Buettner R, Rhodes CJ. 2002a. Pancreatic beta-cell growth and survival-a role in obesity-linked type 2 diabetes? Trends Mol Med 8(8):375-84.
42. Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ. 2002b. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 51(4):966-76.
43. Liu SC, Wang Q, Lienhard GE, Keller SR. 1999. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J Biol Chem 274(25):18093-9.
44. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY. 2001a. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 50(1):69-76.
45. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A, Kaiser N, Donath MY. 2001b. Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50(8):1683-90.
46. Maedler K, Fontana A, Ris F, Sergeev P, Toso C, Oberholzer J, Lehmann R, Bachmann F, Tasinato A, Spinas GA, et al. 2002a. FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication. Proc Natl Acad Sci USA 99(12):8236-41.
47. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY. 2002b. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110(6):851-60.
48. Miyaura C, Chen L, Appel M, Alam T, Inman L, Hughes SD, Milburn JL, Unger RH, Newgard CB. 1991. Expression of reg/PSP, a pancreatic exocrine gene: relationship to changes in islet beta-cell mass. Mol Endocrinol 5(2):226-34.
49. Mohanty S, Spinas GA, Maedler K, Zuellig RA, Lehmann R, Donath MY, Trub T, Niessen M. 2005. Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. Exp Cell Res 303(1):68-78.
50. Montanya E, Nacher V, Biarnes M, Soler J. 2000. Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy. Diabetes 49(8):1341-6.
51. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS. 2004. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306(5695):457-61.
52. Piro S, Anello M, Di Pietro C, Lizzio MN, Patane G, Rabuazzo AM, Vigneri R, Purrello M, Purrello F. 2002. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51(10):1340-7.
53. Pirola L, Johnston AM, Van Obberghen E. 2004. Modulation of insulin action. Diabetologia 47(2):170-4.
54. Rhodes CJ. 2000. IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. J Mol Endocrinol 24(3):303-11.
55. Rhodes CJ. 2005. Type 2 diabetes - a matter of beta-cell life and death? Science 307(5708):380-4.
56. Rui L, Yuan M, Frantz D, Shoelson S, White MF. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277(44):42394-8.
57. Schroder M, Kaufman RJ. 2005. ER stress and the unfolded protein response. Mutat Res 569(1-2):29-63.
58. Simmgen M, Knauf C, Lopez M, Choudhury AI, Charalambous M, Cantley J, Bedford DC, Claret M, Iglesias MA, Heffron H, et al. 2006. Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice. Diabetologia 49(3):552-61.
59. Stocker H, Hafen E. 2000. Genetic control of cell size. Curr Opin Genet Dev 10(5):529-35.
60. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372(6502):182-6.
61. Terauchi Y, Matsui J, Suzuki R, Kubota N, Komeda K, Aizawa S, Eto K, Kimura S, Nagai R, Tobe K, et al. 2003. Impact of genetic background and ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice. J Biol Chem 278(16):14284-90.
62. Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T, Michaelis T, Frahm J, Hemmings BA. 2005. Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 132(13):2943-54.
63. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ. 2001. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7(10):1133-7.
64. Wang Q, Li L, Xu E, Wong V, Rhodes C, Brubaker PL. 2004. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 47(3):478-87.
65. White MF. 1997. The insulin signalling system and the IRS proteins. Diabetologia 40 (Suppl 2):S2-S17.
66. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391(6670):900-4.
67. Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ. 2002. Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 277(51):49676-84.
68. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, Hemmings BA. 2003. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278(34):32124-31.
69. Yang ZZ, Tschopp O, Baudry A, Dummler B, Hynx D, Hemmings BA. 2004. Physiological functions of protein kinase B/Akt. Biochem Soc Trans 32(Pt 2):350-4.